This trial is to study the effects of 5HTP on breathing and anxiety symptoms related to asthma. Subjects will be randomly assigned to take 5HTP or a placebo, then will switch at the halfway point. There are 5 study visits over 12 weeks.
- Allergic Asthma
1 Primary · 2 Secondary · Reporting Duration: 77 days
2 Treatment Groups
1 of 2
1 of 2
20 Total Participants · 2 Treatment Groups
Primary Treatment: 5-hydroxytryptophan · Has Placebo Group · Phase 2
Who is running the clinical trial?
Age 8 - 18 · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is the study open to senior citizens as participants?
"This clinical trial requires prospective participants to be between the ages of 8 and 17. There are 112 trials specifically aimed at youths below 18 years old, as well as 198 for those above 65." - Anonymous Online Contributor
Might I have the opportunity to join this research endeavor?
"This trial requires that applicants have a diagnosis of asthma, are aged between 8 and 17 years old, and out of the 20 total participants being recruited." - Anonymous Online Contributor
Has the Federal Drug Administration sanctioned 5-hydroxytryptophan for clinical use?
"There exists some evidence for 5-hydroxytryptophan's safety, so it was rated a 2 on our scale. Unfortunately there is no efficacy data at this stage of the clinical trial." - Anonymous Online Contributor
Are there any opportunities to join this clinical exploration?
"This clinical trial, which was initially posted on September 12th 2019, is currently in the process of finding participants. The details have been recently updated as of January 20th 2022 according to information found through clinicaltrials.gov." - Anonymous Online Contributor
How many participants have been recruited to this trial?
"Affirmative. Clinicaltrials.gov discloses that this research initiative, which was initially announced on September 12th 2019, is still recruiting participants. Around 20 subjects need to be enrolled from a single medical site." - Anonymous Online Contributor